Dr. Cheryl Lynne Mcbride, DO Emergency Medicine - Sports Medicine Medicare: Medicare Enrolled Practice Location: 751 S Bascom Ave, Emergency Dept, San Jose, CA 95128 Phone: 408-885-5000 |
Lawrence Hart Livingston, M.D Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1060 Saratoga Ave, Ste 920, San Jose, CA 95129 Phone: 408-243-6991 |
Lisa Wen-wen Yang, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 250 Hospital Pkwy, San Jose, CA 95119 Phone: 408-972-6140 |
Lisa Hung, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 |
David C. Plecque, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 International Cir, San Jose, CA 95119 Phone: 408-972-7000 |
Steve Ming-cheng Sun, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 352 La Strada Dr, #12, San Jose, CA 95123 Phone: 408-365-1602 |
Ifrah Abdi Ali, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 N Jackson Ave, San Jose, CA 95116 Phone: 408-729-2819 |
Victor Hsiang Wu, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 North Jackson Avenue, San Jose, CA 95116 Phone: 408-923-7121 |
Elaine Elinor Nelson, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 N Jackson Ave, San Jose, CA 95116 Phone: 408-923-7121 |
Dr. Natalie Badowski Wu, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 455 Oconnor Dr, Suite 250, San Jose, CA 95128 Phone: 408-283-7767 |
Marco R Randazzo, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2105 Forest Ave, San Jose, CA 95128 Phone: 408-947-2500 Fax: 818-587-2493 |
Philip K Hurst, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 751 S Bascom Ave, Emergency Department, San Jose, CA 95128 Phone: 408-885-6986 |
Dr. Daniel Andrew Nelson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 751 S Bascom Ave, San Jose, CA 95128 Phone: 408-885-5000 |
News Archive
Today, Family Research Council Action and the Oklahoma Family Policy Council released a radio advertisement supporting State Representative Rebecca Hamilton's Oklahoma House Bill 3077, currently being reviewed by the Oklahoma State Senate. H.B. 3077 would put an end to the financial lure that draws young women into donating their eggs to fertility clinics, a dangerous procedure that can cause life-threatening complications including kidney failure and blood clots.
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. It is a leading cause of death and the burden is expected to grow worldwide due to the growth and aging of the population, mainly in less developed countries, in which about 82% of the world's population resides. By 2030, the global burden is expected to grow to 21.7 million new cancer cases and 13 million cancer deaths simply due to the growth and aging of the population. Current cancer therapy approaches are based in surgery, radiotherapy and chemotherapy, being the chemotherapy the one that shows the greater efficiency for cancer treatment, mainly in more advanced stages. A major problem with this conventional chemotherapy is its toxicity and it also destroys healthy tissues resulting in systemic toxicity besides beneficial characteristics of killing cancer cells. Anticancer drugs also destroy healthy tissues resulting in systemic toxicity.
Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), as part of a new Collaborative Influenza Vaccine Innovation Centers (CIVICs) program to further develop the universal flu vaccine.
Face masks mandates have led people to spend less time at home, but whether this has exposed Americans to more risk is still a question, according to a new study published Thursday in Scientific Reports.
During the first quarter of the year, we experienced strong growth in sales of Abstral to end customers in Europe. Abstral continued to grow sales in all markets and is now the market leader in cancer pain drugs in the UK.
› Verified 4 days ago